Dr Carrie Marie Putka, AUD | |
1 Perkins Sq, Ent Center, Akron, OH 44308-1063 | |
(330) 543-4939 | |
(330) 543-4931 |
Full Name | Dr Carrie Marie Putka |
---|---|
Gender | Female |
Speciality | Qualified Audiologist |
Experience | 15 Years |
Location | 1 Perkins Sq, Akron, Ohio |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881913507 | NPI | - | NPPES |
1473203 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | A01694 (Ohio) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
Misonix, Inc., a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide has entered into a new three-year exclusive distribution agreement with MD Solutions Australasia Pty. Ltd., based in Newport, Victoria, Australia.
ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi platform, today reported that the first patient with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) has enrolled in the "Wolverine" Phase II study and been treated with PNT2258.
Whole-body PET (positron emission tomography) scans done three months after completion of cervical cancer therapy can ensure that patients are disease-free or warn that further interventions are needed, according to a study at Washington University School of Medicine in St. Louis.
The Miriam Hospital is part of a research collaboration that has received a $20 million grant from the National Institutes of Health (NIH) to develop an intravaginal ring (IVR) that can deliver powerful antiretroviral (ARV) drugs to prevent the spread of sexually transmitted HIV in women.
› Verified 8 days ago
Provider Name | The Cleveland Clinic Foundation |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
Misonix, Inc., a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide has entered into a new three-year exclusive distribution agreement with MD Solutions Australasia Pty. Ltd., based in Newport, Victoria, Australia.
ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi platform, today reported that the first patient with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) has enrolled in the "Wolverine" Phase II study and been treated with PNT2258.
Whole-body PET (positron emission tomography) scans done three months after completion of cervical cancer therapy can ensure that patients are disease-free or warn that further interventions are needed, according to a study at Washington University School of Medicine in St. Louis.
The Miriam Hospital is part of a research collaboration that has received a $20 million grant from the National Institutes of Health (NIH) to develop an intravaginal ring (IVR) that can deliver powerful antiretroviral (ARV) drugs to prevent the spread of sexually transmitted HIV in women.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Carrie Marie Putka, AUD 1 Perkins Sq, Ent Center, Akron, OH 44308-1063 Ph: (330) 543-4939 | Dr Carrie Marie Putka, AUD 1 Perkins Sq, Ent Center, Akron, OH 44308-1063 Ph: (330) 543-4939 |
News Archive
Misonix, Inc., a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide has entered into a new three-year exclusive distribution agreement with MD Solutions Australasia Pty. Ltd., based in Newport, Victoria, Australia.
ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi platform, today reported that the first patient with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) has enrolled in the "Wolverine" Phase II study and been treated with PNT2258.
Whole-body PET (positron emission tomography) scans done three months after completion of cervical cancer therapy can ensure that patients are disease-free or warn that further interventions are needed, according to a study at Washington University School of Medicine in St. Louis.
The Miriam Hospital is part of a research collaboration that has received a $20 million grant from the National Institutes of Health (NIH) to develop an intravaginal ring (IVR) that can deliver powerful antiretroviral (ARV) drugs to prevent the spread of sexually transmitted HIV in women.
› Verified 8 days ago
Ohio Hearing Health, Inc, Audiologist Medicare: Medicare Enrolled Practice Location: 799 White Pond Dr, Suite D, Akron, OH 44320 Phone: 330-665-5200 | |
Mariah P Crabtree, AUD. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 395 E Market St, Akron, OH 44304 Phone: 330-762-8959 | |
Mrs. Deborah Ann Miller, M.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 300 Locust St Ste 100, Akron, OH 44302 Phone: 330-379-9070 Fax: 330-379-2358 | |
Lisa M Oswald, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 701 White Pond Dr, Suite 300, Akron, OH 44320 Phone: 330-572-1011 Fax: 330-572-1018 | |
Mrs. Madhu Gupta, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3577 N Shore Dr, Akron, OH 44333 Phone: 330-666-5418 | |
Dr. Amy Katherine Welman, AU.D Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2800 S Arlington Rd, Suite 102, Akron, OH 44312 Phone: 330-644-1932 Fax: 330-475-0780 | |
Dr. Erin L. Miller, AU.D. Audiologist Medicare: May Accept Medicare Assignments Practice Location: The University Of Akron, Audiology And Speech Center, Akron, OH 44325 Phone: 330-972-8160 Fax: 330-972-7884 |